Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-13

Clinical Trial Update: A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery [Phase 3]

View source ↗

Summary

Completed Phase 3 trial assessing the efficacy and safety of a 30 mcg sublingual sufentanil tablet for postoperative pain after abdominal surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sufentanil Sublingual Tablet 30 mcg (sufentanil)

Snippet

Sponsor: Talphera, Inc | Conditions: Post-Operative Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-02-13